Endothelin Receptor Antagonists and Agonists
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
Endothelin Receptor Blockers in Cardiovascular Disease | Circulation
Endothelin | Pharmacological Reviews
The Endothelin Receptor Antagonist Macitentan Ameliorates Endothelin-Mediated Vasoconstriction and Promotes Neuroprotection of Retinal Ganglion Cells in Rats | bioRxiv
Nonpeptide endothelin receptor antagonists and their relative... | Download Scientific Diagram
The Endothelin System | Encyclopedia MDPI
Endothelin: 20 years from discovery to therapy This article is one of a selection of papers published in the special issue (part 2 of 2) on Forefronts in Endothelin.
Endothelin and endothelin receptors in the renal and cardiovascular systems - ScienceDirect
Endothelin and the heart in health and diseases - ScienceDirect
Endothelin receptor antagonists in pulmonary arterial hypertension | European Respiratory Society
Endothelins | NEJM
The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis | SpringerLink
Endothelin-Receptor Antagonists beyond Pulmonary Arterial Hypertension: Cancer and Fibrosis | Journal of Medicinal Chemistry
SONAR propels endothelin A receptor antagonists to success | Nature Reviews Nephrology
Dual endothelin receptor antagonism increases resting energy expenditure in people with increased adiposity | American Journal of Physiology-Endocrinology and Metabolism
Current state of endothelin receptor antagonism in hypertension and pulmonary hypertension - Kazuya Miyagawa, Noriaki Emoto, 2014
Endothelin | Pharmacological Reviews
Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases | Nature Reviews Rheumatology
Endothelin receptor antagonists – their role in pulmonary medicine - ScienceDirect
Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism - ScienceDirect
Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve? - ScienceDirect
JCM | Free Full-Text | Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
